Back to top

Tango Therapeutics price target raised to $40 from $36 at Mizuho

Mizuho raised the firm’s price target on Tango Therapeutics (TNGX) to $40 from $36 and keeps an Outperform rating on the shares. The firm believes ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Revolution Medicines, Inc. (RVMD)

Tango Therapeutics, Inc. (TNGX)